business
4d molecular therapeutics CEO Kirn sells $19,257 in shares
4d molecular therapeutics CEO Kirn sells $19,257 in shares
Read full story on Investing.com → More top storiesAlso covered by
Yahoo Finance
KalVista's (KALV) Chief Development Officer Sells 33,800 Shares for $905,000
Yahoo Finance
An Oruka Therapeutics (ORKA) Insider Sold 105,000 Shares Worth $6.2 Million
Decrypt
Strategy Shares Fall for Second Straight Day After $56 Billion Bitcoin Giant Sells BTC
Yahoo Finance
Chief Risk Officer Sells 11,250 Shares of Regional Insurer, According to Latest SEC Filing
Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop